Abstract
In January 2021, we wrote a letter to the editor of the Journal of Global Antimicrobial Resistance about the possible role of vaccine or monoclonal therapy in the fight against SARS-CoV-2 [1]. The virus had already been infecting the world for 12 months and the first variants were emerging, such as the UK variant, B.1.1.7, […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
